Seminar Program Evonik Health Care

Overview

What’s next for LNPs? Discover the innovations shaping RNA therapeutics. Join Evonik and Sartorius for a focused, expert-led workshop exploring the latest strategies in lipid nanoparticle (LNP) development across the full workflow – from lipid design and formulation screening to clinical scale-up.

This half-day program is designed to address the evolving complexities of LNP design and manufacturing, while highlighting emerging strategies to accelerate the development of RNA therapeutics.

Key learnings for participants

Expert-Led Insights & Advancements: Hear from leading scientists presenting real-world research while exploring current approaches and advancements in LNP development, including key considerations in design, formulation, scale-up, and emerging RNA therapeutic applications.
Engaging Panel Discussion: Join a dynamic panel as they address the challenges and future opportunities in LNP technologies.
Networking & Collaboration: Connect with peers, collaborators, and leaders from industry and academia during dedicated networking sessions.
Live Demonstrations: Preview the latest tools and workflows supporting LNP development featuring Sartorius’s LNP Formulation pipette & PATfix® LNP Switcher platform.

Agenda

The workshop will start at 11:45 a.m. on Tuesday, July 14, 2026, and finish at 06:00 p.m. on the same day. To see the detailed workshop program please click here .

11:45 am - 12:00 pm | Arrival & Registration

12:00 pm - 01:00 pm | Lunch & Networking

01:00 pm - 01:30 pm | Plenary Talk: Advancing Quality and Process Understanding Across the Nucleic Acid and LNP Biopharmaceutical Chain Toward Rational Design and Controlled Production
Tristan Kovačič, Project Manager Process Analytics Development
Sartorius

01:20 pm - 01:40 pm | Boosting Lipid Nanoparticle Performance with Cholesterol Derivatives
Dr. Daniel Costa, Senior Scientist, Nucleic Acid Delivery
Evonik

01:40 pm - 02:00 pm | The Versatile Ionizable Lipid AMG1541 Enables Distinct LNP Formulations for High-Potency Intramuscular Vaccines and Intravenous Delivery of Micro-Dystrophin and Cas9 mRNA to Restore Dystrophin Expression and Muscle Function in a DMD Mouse Model
Dr. Arnab Rudra, Scientist (Boston Children’s Hospital)
Koch Institute, MIT

02:00 pm - 02:20 pm | Break

02:20 pm - 02:40 pm | High-Throughput RNA-LNP Formulation Screening Enabled By Liquid-Handling Automation
Dr. Yuji Takeda, Senior Scientist, Lipid Nanoparticle Formulation
Sartorius

02:40 pm - 03:00 pm | Beyond Ionizable Lipids: Cationic LNPs for Efficient mRNA Delivery and Immunogenicity
Prof. Hai-Quan Mao, Director of Institute for NanoBioTechnology
Johns Hopkins University

03:00 pm - 03:20 pm | Blueprint to Engineering and Scaling LNPs for Clinical Development
Dr. Annette Bak, Head of Advanced Drug Delivery
AstraZeneca

03:20 pm - 03:45 pm | Panel with all speakers

03:45 pm - 05:30 pm | Networking Reception & Live Demos of Sartorius’s LNP Formulation pipette & PATfix® LNP Switcher platform